Zobrazeno 1 - 10
of 11
pro vyhledávání: '"John PH Wilding"'
Autor:
Emily Brown, Victoria S Sprung, Graham J Kemp, John PH Wilding, Malcolm Burgess, Daniel J Cuthbertson, A Margot Umpleby, Jason C G Halford, Andrej Stancak, Moon M Wilton, Joanne A Harrold, Elaine Howarth
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Introduction The newer glucose-lowering therapies for type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonists (GLP1-RAs) and the sodium-glucose co-transporter 2 inhibitors (SGLT2i), have additional clinical benefits beyond improving glyc
Externí odkaz:
https://doaj.org/article/e58426e12bf4422080cccd3ed1011943
Autor:
Victoria S Sprung, Graham J Kemp, John PH Wilding, Valerie Adams, Kieran Murphy, Malcolm Burgess, Stephen Emegbo, Matthew Thomas, Alexander J Needham, Andrew Weimken, Richard J Schwab, Ari Manuel, Sonya E Craig, Daniel J Cuthbertson
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
Introduction Obstructive sleep apnoea (OSA) and type 2 diabetes mellitus (T2DM) often occur concurrently, and untreated OSA may potentially amplify the high risk of cardiovascular disease in T2DM. Compliance with continuous positive airway pressure (
Externí odkaz:
https://doaj.org/article/81600400deda44a58b7e80246290a587
Autor:
Ian W Seetho, Adela Ramírez-Torres, Amaya Albalat, William Mullen, Harald Mischak, Robert J Parker, Sonya Craig, Nick Duffy, Kevin J Hardy, Jatin G Burniston, John PH Wilding
Publikováno v:
Sleep Science, Vol 8, Iss 2, Pp 58-67 (2015)
Introduction: Obstructive sleep apnoea (OSA) is common in obesity and is associated with cardiovascular and metabolic complications. Continuous positive airway pressure (CPAP) in OSA may lead to physiological changes reflected in the urinary proteome
Externí odkaz:
https://doaj.org/article/6a43a7c325a146419e56822396467fb1
Autor:
Sarah Chapelsky, Leigh Perreault, Melanie Davies, Juan P Frias, Peter Norkjaer Laursen, Ildiko Lingvay, Sriram Machineni, Anette Varbo, John Ph Wilding, Signe Olrik Rytter Wallenstein, Carel W Le Roux
Publikováno v:
Canadian Journal of Diabetes. 46:S4-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf589348d97f1af24c34db97caf7d33f
https://doi.org/10.1016/j.jcjd.2022.09.012
https://doi.org/10.1016/j.jcjd.2022.09.012
Autor:
null John PH Wilding, null Rachel L Batterham, null Melanie Davies, null Luc F Van Gaal, null Kristian Kandler, null Katerina Konakli, null Ildiko Lingvay, null Barbara M McGowan, null Tugce Kalayci Oral, null Julio Rosenstock, null Thomas A Wadden, null Sean Wharton, null Koutaro Yokote, null Robert F Kushner, null for the STEP 1 Study Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b254d77e0dbc2c9cacc0389ce2a21fd2
https://doi.org/10.1111/dom.14725/v2/response1
https://doi.org/10.1111/dom.14725/v2/response1
Autor:
Emily, Brown, Moon M, Wilton, Victoria S, Sprung, Joanne A, Harrold, Jason C G, Halford, Andrej, Stancak, Malcolm, Burgess, Elaine, Howarth, A Margot, Umpleby, Graham J, Kemp, John Ph, Wilding, Daniel J, Cuthbertson
Publikováno v:
BMJ Open
Introduction The newer glucose-lowering therapies for type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonists (GLP1-RAs) and the sodium-glucose co-transporter 2 inhibitors (SGLT2i), have additional clinical benefits beyond improving glyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::714add0887df15066d2ec9fad2e80071
https://pubmed.ncbi.nlm.nih.gov/34285005
https://pubmed.ncbi.nlm.nih.gov/34285005
Autor:
David Berg, Stephen D. Wiviott, Itamar Raz, Petr Jarolim, Erica L. Goodrich, Ofri Mosenzon, Avivit Cahn, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John PH Wilding, Ingrid Gause-Nilsson, Ann Hammarstedt, Jan Oscarsson, Marc Steven Sabatine, David A. Morrow
Publikováno v:
Journal of the American College of Cardiology. 79:1526
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e2091125a8e91031256a6ad005c080
https://doi.org/10.1016/s0735-1097(22)02517-7
https://doi.org/10.1016/s0735-1097(22)02517-7
Chapter 3 covers lifestyle modification information, including healthy nutrition, obesity, and smoking cessation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1240198ed0cd0a7017ed1903ef6dbf8
https://doi.org/10.1093/med/9780199565979.003.0003
https://doi.org/10.1093/med/9780199565979.003.0003
Autor:
John PH Wilding
Publikováno v:
Medicine. 31:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c70286fcae011810c72875b6bae92944
https://doi.org/10.1383/medc.31.4.1.27965
https://doi.org/10.1383/medc.31.4.1.27965